Mark A. Demitrack
2023
In 2023, Mark A. Demitrack earned a total compensation of $1M as SVP and Chief Medical Officer at Trevena, a 50% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $218,025 |
|---|---|
| Salary | $510,120 |
| Stock Awards | $290,850 |
| Other | $13,200 |
| Total | $1,032,195 |
Demitrack received $510.1K in salary, accounting for 49% of the total pay in 2023.
Demitrack also received $218K in non-equity incentive plan, $290.9K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Mark A. Demitrack's compensation ranked 1,175th out of 3,006 executives tracked by ExecPay. In other words, Demitrack earned more than 60.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,175 out of 3,006 | 61st |
Division Manufacturing | 701 out of 1,650 | 58th |
Major group Chemicals And Allied Products | 469 out of 918 | 49th |
Industry group Drugs | 458 out of 881 | 48th |
Industry Pharmaceutical Preparations | 315 out of 637 | 51st |
Source: SEC filing on April 29, 2024.
Demitrack's colleagues
We found two more compensation records of executives who worked with Mark A. Demitrack at Trevena in 2023.